This 2 half-days course presents a blend of Orphan Drugs regulatory guidance and approaches to clinical trials and assessment of evidence. The course covers the legal basis for approvals, how to design studies and a look at some recent methodological ideas that have been proposed. Evidence- Based Medicine and clear reporting of studies will be thoroughly discussed.